Circulating TGF-Β1 as a reliable biomarker for chronic kidney disease progression in the African-American population

25Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Progressive renal fibrosis is common to all chronic kidney diseases (CKD). Suthanthiran and colleagues identified a positive association between transforming growth factor-Β1 and several risk factors for CKD progression in African Americans but not in whites. This study offers a possible explanation for the higher prevalence of end-stage renal disease in African Americans and highlights the need for a better therapeutic strategy for this population. © 2009 International Society of Nephrology.

Cite

CITATION STYLE

APA

Lee, S. B., Kanasaki, K., & Kalluri, R. (2009). Circulating TGF-Β1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2009.130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free